Straumann is a world-leading dental solution provider in implant and restorative dentistry and oral tissue regeneration. We are committed to sustainable growth through innovative research and technology. Straumann's goal is to provide investors and capital markets with relevant information that contributes to a correct valuation of the company.
Media releases
Upcoming events |
Financial informationAnnual Report 2009 Further information |
| Straumann share | Zürich (SWX): STMN 226,80
29 July 2010 17:31 (CET)
|
 |
